0001140361-17-018048.txt : 20170503
0001140361-17-018048.hdr.sgml : 20170503
20170503125509
ACCESSION NUMBER: 0001140361-17-018048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170503
DATE AS OF CHANGE: 20170503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEVRO CORP
CENTRAL INDEX KEY: 0001444380
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 562568057
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-251-0005
MAIL ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elghandour Rami
CENTRAL INDEX KEY: 0001613689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36715
FILM NUMBER: 17808280
MAIL ADDRESS:
STREET 1: 15 BARCELONA CIR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
doc1.xml
FORM 4
X0306
4
2017-05-01
0
0001444380
NEVRO CORP
NVRO
0001613689
Elghandour Rami
C/O NEVRO CORP.
1800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
1
1
0
0
President & CEO
Common Stock
2017-05-01
4
M
0
10000
3.60
A
105224
D
Common Stock
2017-05-01
4
S
0
10000
95.0302
D
95224
D
Stock Option (right to buy)
3.60
2017-05-01
4
M
0
10000
0.00
D
2023-05-14
Common Stock
10000
65051
D
Includes 94,739 restricted stock units.
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option, representing the right to purchase 88,207 shares of the Issuer's common stock, vests and becomes exercisable in respect to 1/48th of the original number of shares subject to the option on each monthly anniversary measured from May 15, 2013 (the "Vesting Commencement Date"), such that 100% of the shares underlying the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew Galligan, as Attorney-in-Fact for Rami Elghandour
2017-05-03